TEAMM Pharmaceuticals Announces Acquisition of a New Drug Delivery Technology
TEAMM Acquires Patent Pending Sustained Release Technology for Application in Multiple Delivery Platforms, to Further Enhance Its Development Pipeline
27-Oct-2003 -
EAMM Pharmaceuticals, Inc. ("TEAMM"), a specialty pharmaceutical company, and wholly owned subsidiary of Accentia, Inc. ("Accentia" or the "Company"), based in Tampa, Florida, announces the recent acquisition of worldwide rights for an extended release drug delivery technology. The process ...
biopharmaceuticals
drug delivery
solvents